Singapore markets close in 18 minutes

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,335.40-18.20 (-1.34%)
As of 9:27AM BST. Market open.
Full screen
Previous close1,353.60
Open1,344.80
Bid1,334.80 x 0
Ask1,335.20 x 0
Day's range1,324.40 - 1,346.00
52-week range1,324.40 - 1,857.00
Volume1,551,086
Avg. volume7,247,404
Market cap67.002B
Beta (5Y monthly)0.34
PE ratio (TTM)10.06
EPS (TTM)132.70
Earnings date28 Oct 2020
Forward dividend & yield0.76 (5.51%)
Ex-dividend date13 Aug 2020
1y target est1,644.50
  • GlaxoSmithKline (GSK) Dips More Than Broader Markets: What You Should Know
    Zacks

    GlaxoSmithKline (GSK) Dips More Than Broader Markets: What You Should Know

    GlaxoSmithKline (GSK) closed at $35.35 in the latest trading session, marking a -1.91% move from the prior day.

  • GSK to launch late-stage testing of syncytial virus vaccine
    Reuters

    GSK to launch late-stage testing of syncytial virus vaccine

    GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing, encouraged by mid-stage trial results. RSV vaccine development has been fraught with setbacks for decades but the pharma industry is gearing up to bring a first inoculation to market over the next few years. GSK said a Phase I/II trial with about 1,000 healthy adults aged 60-80 showed that the vaccine prompted a "robust" increase in antibodies and immune cells one month after injection, indicating a stimulated immune system.

  • Why Surface Oncology Stock Soared Today
    Motley Fool

    Why Surface Oncology Stock Soared Today

    What happened Shares of Surface Oncology (NASDAQ: SURF) were soaring 19.1% higher as of 3:26 p.m. EDT on Monday. The big jump came after StreetInsider reported that Surface Oncology has hired an investment bank to explore selling the company, with GlaxoSmithKline (NYSE: GSK) expressing interest in acquiring the biotech.